Address: Units 601-605, 6/F, Biotech Centre One, Hong Kong Science Park, Shatin, New Territories, Hong Kong
Tel: (852) 2111 2123
Fax: (852) 2111 9762
Website: https://www.haikanglife.com/
Hai Kang Life Corporation Ltd. (HKLife), established in 1999, is a pioneering molecular diagnostic (MDx) company dedicated to revolutionizing clinical diagnostics and providing effective platforms for point of care (POC) applications focusing on personalized medicine as well as pre-emptive surveillance of emerging pathogens and diseases. It is strategically located at the hub of Asian biotechnology, whereby its research and testing laboratories are located in Hong Kong Science and Technology Park (HK), a booming biotech hub, and Beijing, where there is an enormous opportunity to secure competitive leverage in the local biotech business.
HKLife products utilize molecular technologies, including the electric-field-assisted-diagnostic (EFAD) technology. This novel innovation incorporates a patented electric-field technology which allows for the identification of multiple pathogens simultaneously in a simple and cost-effective manner. The system’s simplicity and user-friendliness allow for effective diagnosis anywhere and everywhere. Nevertheless, this technology could assume a significant role in the near future in personalized medicine, disease surveillance, prognosis, the agnostics, and even cancer detection. With EFAD, HKLife delivers innovative and cutting-edge clinical solutions to the world, enabling rapid diagnosis and outbreak monitoring.